Literature DB >> 30266153

Alagille Syndrome.

Ellen Mitchell1, Melissa Gilbert2, Kathleen M Loomes3.   

Abstract

Alagille syndrome is a complex multisystem autosomal dominant disorder with a wide variability in penetrance of clinical features. A majority of patients have pathogenic mutations in either the JAG1 gene, encoding a Notch pathway ligand, or the receptor NOTCH2. No genotype-phenotype correlations have been found in any organ system. Liver disease is a major cause of morbidity in this population, whereas cardiac and vascular involvement accounts for most of the mortality. Current therapies are supportive, but the future is promising for the development of targeted interventions to augment Notch pathway signaling in involved tissues.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholestasis; JAG1; Liver transplant; NOTCH2; Pediatric

Mesh:

Substances:

Year:  2018        PMID: 30266153     DOI: 10.1016/j.cld.2018.06.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  24 in total

Review 1.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 2.  Inherited Cholestatic Diseases in the Era of Personalized Medicine.

Authors:  Alyssa Goldberg; Cara L Mack
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-04-04

Review 3.  Skin Changes in Cirrhosis.

Authors:  Adhyatm Bhandari; Rahul Mahajan
Journal:  J Clin Exp Hepatol       Date:  2021-12-28

Review 4.  Gene Therapy for Acquired and Genetic Cholestasis.

Authors:  Javier Martínez-García; Angie Molina; Gloria González-Aseguinolaza; Nicholas D Weber; Cristian Smerdou
Journal:  Biomedicines       Date:  2022-05-26

Review 5.  Role of YAP1 Signaling in Biliary Development, Repair, and Disease.

Authors:  Laura Molina; Kari Nejak-Bowen; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2022-01-24       Impact factor: 6.512

Review 6.  Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.

Authors:  Angelo Giuseppe Condorelli; May El Hachem; Giovanna Zambruno; Alexander Nystrom; Eleonora Candi; Daniele Castiglia
Journal:  J Biomed Sci       Date:  2021-05-09       Impact factor: 8.410

7.  Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11.

Authors:  Wei Zhu; Yu-Shan Cheng; Miao Xu; Atena Farkhondeh; Jeanette Beers; Jizhong Zou; Chengyu Liu; Karsten Baumgaertel; Steven Rodems; Wei Zheng
Journal:  Stem Cell Res       Date:  2021-04-27       Impact factor: 1.587

8.  Oral manifestations of Alagille syndrome.

Authors:  Anne-Laure Bonnet; Victor Greset; Tiphaine Davit-Beal
Journal:  BMJ Case Rep       Date:  2020-05-31

9.  Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors.

Authors:  Laura M Molina; Junjie Zhu; Qin Li; Tirthadipa Pradhan-Sundd; Yekaterina Krutsenko; Khaled Sayed; Nathaniel Jenkins; Ravi Vats; Bharat Bhushan; Sungjin Ko; Shikai Hu; Minakshi Poddar; Sucha Singh; Junyan Tao; Prithu Sundd; Aatur Singhi; Simon Watkins; Xiaochao Ma; Panayiotis V Benos; Andrew Feranchak; George Michalopoulos; Kari Nejak-Bowen; Alan Watson; Aaron Bell; Satdarshan P Monga
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.423

10.  JAGGED1 stimulates cranial neural crest cell osteoblast commitment pathways and bone regeneration independent of canonical NOTCH signaling.

Authors:  Archana Kamalakar; Jay M McKinney; Daniel Salinas Duron; Angelica M Amanso; Samir A Ballestas; Hicham Drissi; Nick J Willett; Pallavi Bhattaram; Andrés J García; Levi B Wood; Steven L Goudy
Journal:  Bone       Date:  2020-09-25       Impact factor: 4.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.